| Arlene Lewis, MD | |
|
609 Jefferson Davis Hwy, Suite 201, Fredericksburg, VA 22401-4436 | |
| (540) 372-6650 | |
| (540) 372-7699 |
| Full Name | Arlene Lewis |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 609 Jefferson Davis Hwy, Fredericksburg, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225014095 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101229809 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Arlene Lewis, MD 609 Jefferson Davis Hwy, Suite 201, Fredericksburg, VA 22401-4436 Ph: (540) 372-6650 | Arlene Lewis, MD 609 Jefferson Davis Hwy, Suite 201, Fredericksburg, VA 22401-4436 Ph: (540) 372-6650 |
News Archive
A new study finds that following mild COVID-19, children are more likely to remain seronegative than adults, irrespective of the viral load or symptom severity.
Canadian researchers have discovered a new and direct molecular mechanism to stop cancer cells from proliferating. In the prestigious journal Nature Cell Biology, scientists from Université de Montréal show that a disruption of a fine balance in the composition of ribosomes (huge molecules that translate the genetic code into proteins) results in a shutdown of cancer cell proliferation, triggering a process called senescence.
Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on May 18, 2010, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5550(a)(2).
The deadline for approval or rejection of new drugs by the Food and Drug Administration (FDA) could be extended by two months say U.S. regulators and drug industry officials.
› Verified 2 days ago
Dr. Donna C Wicker, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4701 Spotsylvania Parkway, Suite 200, Fredericksburg, VA 22401 Phone: 540-834-5420 Fax: 540-834-5421 | |
Brenda Hines, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2216 Princess Anne St, Fredericksburg, VA 22401 Phone: 540-370-4380 | |
Ms. Samhita Bhat, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1071 Care Way Ste 101, Fredericksburg, VA 22401 Phone: 540-374-3100 Fax: 540-374-3102 | |
Zeenat S. Patel, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1011 Care Way, Suite 200, Fredericksburg, VA 22401 Phone: 540-373-4900 Fax: 540-373-5195 | |
Dr. Pushpinder Dhillon, M.D., F.A.C.O.G Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 412 Cambridge Street, Fredericksburg, VA 22405 Phone: 540-373-7667 Fax: 540-373-7676 | |
Charis A Venditti, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Chatham Square Office Park, Fredericksburg, VA 22405 Phone: 540-322-2233 | |
Peter Steven Pyatak, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1071 Care Way Ste 101, Fredericksburg, VA 22401 Phone: 540-374-3100 Fax: 540-374-3102 |